← TrialMatch
HomeTrials

Multimodal mAgnetic Resonance imaGIng in Cardiovascular Disease

This single-center, prospective, observational cohort study aims to evaluate the clinical application value of multi-modal cardiovascular magnetic resonance (CMR) imaging in patients with cardiovascular diseases (CVD). While traditional imaging methods have limitations in fully evaluating myocardial tissue characterist

Condition(s)Cardiovascular Diseases, Ischemic Heart Disease (IHD), Cardiomyopathy, Myocarditis, Heart Valve Diseases
StatusRecruiting
Study typeObservational
SummaryThis single-center, prospective, observational cohort study aims to evaluate the clinical application value of multi-modal cardiovascular magnetic resonance (CMR) imaging in patients with cardiovascular diseases (CVD). While traditional imaging methods have limitations in fully evaluating myocardial tissue characteristics, multi-modal CMR offers a comprehensive, non-invasive "one-stop" assessment. It can simultaneously evaluate heart structure, function, tissue features (such as fibrosis and edema), and hemodynamics. The study plans to enroll patients with suspected or confirmed CVD. Participants will undergo a comprehensive multi-modal CMR scan (including Cine, T1/T2 mapping, Late Gadolinium Enhancement, and 4D flow sequences) as part of their evaluation. By tracking clinical outcomes, th
Who can participateInclusion Criteria: * Aged 18 years and older, with no gender restrictions. Clinically suspected or confirmed cardiovascular disease (including but not limited to ischemic heart disease, non-ischemic cardiomyopathy, myocarditis, valvular disease, etc.), requiring a cardiac magnetic resonance (CMR) examination to determine the etiology or evaluate myocardial tissue characteristics. No contraindications to magnetic resonance examination, and able to cooperate with breath-holding instructions. Voluntarily participate in this study and sign a written informed consent form. Exclusion Criteria: * Absolute contraindications: Implantation of non-MRI compatible metallic foreign bodies (e.g., old pacemakers, implantable cardioverter-defibrillators \[ICD\], aneurysm clips, etc.). Relative contraindic
Ages18 Years
SexAll
Lead sponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University
LocationsHangzhou, Zhejiang, China
Start date2026-01-01
NCT IDNCT07617844
Official listinghttps://clinicaltrials.gov/study/NCT07617844

🔍 Search all trials →